Narrow search
Showing 1 - 10 of 334
Cover Image
Hybrid risk adjustment for pharmaceutical benefits
García-Goñi, Manuel; Ibern, Pere; Inoriza, José María - In: The European journal of health economics : HEPAC ; … 10 (2009) 3, pp. 299-308
Persistent link: https://www.econbiz.de/10003857250
Cover Image
How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives
Özden Gür Ali; Topaler, Başak - In: The European journal of health economics : HEPAC ; … 12 (2011) 6, pp. 553-562
Persistent link: https://www.econbiz.de/10009376933
Cover Image
Prevalence and treatment costs of type 2 diabetes in Germany and the effects of social and demographical differences
Sittig, D. T.; Friedel, Heiko; Wasem, Jürgen - In: The European journal of health economics : HEPAC ; … 16 (2015) 3, pp. 305-311
Persistent link: https://www.econbiz.de/10011299646
Cover Image
Patients whose GP knows complementary medicine tend to have lower costs and live longer
Kooreman, Peter; Baars, Erik W. - In: The European journal of health economics : HEPAC ; … 13 (2012) 6, pp. 769-776
Persistent link: https://www.econbiz.de/10009667246
Cover Image
Endogenous technological change in medicine and its impact on healthcare costs : evidence from the pharmaceutical market in Taiwan
Hsieh, Chee-Ruey; Liu, Ya Ming; Chang, Chia-lin - In: The European journal of health economics : HEPAC ; … 14 (2013) 2, pp. 287-295
Persistent link: https://www.econbiz.de/10009719729
Cover Image
Drug expenditure of high-cost patients and their characteristics in Finland
Saastamoinen, Leena K.; Verho, Jouko - In: The European journal of health economics : HEPAC ; … 14 (2013) 3, pp. 495-502
Persistent link: https://www.econbiz.de/10009757484
Cover Image
Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation : results for Canada, Italy, Sweden and Switzerland
Nilsson, Jonas; Åkerborg, Örjan; Bégo-Le Bagousse, … - In: The European journal of health economics : HEPAC ; … 14 (2013) 3, pp. 481-493
Persistent link: https://www.econbiz.de/10009757486
Cover Image
Orphan drugs policies : a suitable case for treatment ; editorial
Drummond, Michael F.; Towse, Adrian - In: The European journal of health economics : HEPAC ; … 15 (2014) 4, pp. 335-340
Persistent link: https://www.econbiz.de/10010360871
Cover Image
Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures? : editorial
Farfan-Portet, María-Isabel; Gerkens, Sophie; … - In: The European journal of health economics : HEPAC ; … 15 (2014) 3, pp. 223-228
Persistent link: https://www.econbiz.de/10010361510
Cover Image
Could co-payments on drugs help to make EU health care systems less open to political influence?
Garattini, Livio; Van de Vooren, Katelijne - In: The European journal of health economics : HEPAC ; … 14 (2013) 5, pp. 709-713
Persistent link: https://www.econbiz.de/10010195586